Future Outlook: "Multi-Target" Theranostics and the End of Resistance in the 2026 Sector

added blog Health

2026-01-05 08:48:14 -

As we move through the second half of 2026, the industry is looking toward "Multi-Target" theranostics to solve the problem of "Tumor Heterogeneity." Sometimes, a cancer tumor has different types of cells on the inside than on the outside, which can allow it to "hide" from a medicine that only looks for one marker. In late 2026, the first "Bispecific" tracers are being used, which can bind to...

0 Comments 0 Shares 23 Views 0 Reviews